Last reviewed · How we verify
Tylenol® Caplets
At a glance
| Generic name | Tylenol® Caplets |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pharmacokinetic Interaction Between Ibuprofen and Acetaminophen, Tablets Administered Individually or in Combination (PHASE1)
- Bioequivalence Study for Mejoral 500 Product (NA)
- A Relative Bioavailability Study of Acetaminophen 650 mg Extended Release Gelcaps Under Fed Condition (NA)
- A Relative Bioavailability Study of Acetaminophen 650 mg Extended Release Gelcaps Under Fasting Condition (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tylenol® Caplets CI brief — competitive landscape report
- Tylenol® Caplets updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI